Scopolamine API Market is Expected to be Powered by Rapid Growth in Pharmaceutical Industry
![]() |
Scopolamine API Market |
Scopolamine API is the active pharmaceutical ingredient used in
manufacturing a variety of pharmaceutical drugs. Scopolamine is an alkaloid
compound extracted from plants in the nightshade family, primarily Datura and
is primarily used to treat motion sickness and nausea. Some key drugs manufactured
using scopolamine API include transdermal patches for motion sickness and
anticholinergic drugs. Scopolamine finds applications in ophthalmology for
treatment of conjunctivitis and mydriasis.
The global scopolamine API market is estimated to be valued at US$ 308.49 Mn in
2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to
2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
Rapid growth in the global pharmaceutical industry has been a key driver for
the scopolamine API market. The growing prevalence of disorders requiring
treatment with anticholinergic drugs and emergence of new application areas for
scopolamine is also fueling demand. Furthermore, growing emphasis on motion sickness
treatment, especially among travelers is supporting the need for
scopolamine-based drugs.
However, stringent regulations pertaining to extraction and manufacturing of
scopolamine pose a challenge for market players. Sustaining regulatory
approvals is a major undertaking for companies.
Segment Analysis
The global scopolamine API market is dominated by the pharmaceutical segment.
The pharmaceutical segment currently holds around 70% market share owing to the
high usage of scopolamine API in manufacturing medicines for motion sickness,
postoperative nausea, and vomiting. Scopolamine API finds major application in
manufacturing anti-cholinergic and anti-motion sickness drugs. Within the
pharmaceutical segment, the anti-motion sickness drugs sub-segment is the
dominating one due to high prevalence of motion sickness among people.
PEST Analysis
Political: Regulations regarding the manufacturing and usage of controlled
substances can impact the scopolamine API market. Any changes in these
regulations related to production or international trade of scopolamine API
will affect the market.
Economic: Fluctuations in currency exchange rates and economic performance of
key markets can influence the profitability of players operating in the
scopolamine API market. The overall economic growth also determines the
healthcare spending of countries which direct impacts the demand for
scopolamine API.
Social: Increasing preference for over-the-counter medications for minor health
issues like motion sickness is driving the demand for scopolamine API. Growing
health awareness and self-medication practices are supporting the social
factors of the market.
Technological: Emergence of improved and novel drug delivery mechanisms is
facilitating the development of advanced anti-motion sickness drugs using
scopolamine API. Continuous R&D for enhancing efficacy and safety is also a
key technological factor.
Key Takeaways
The Global
Scopolamine API Market Demand is estimated to be valued at US$ 308.49
Mn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period
2023 to 2030.
The global scopolamine API market is expected to witness high growth over the
forecast period. Asia Pacific region currently dominates the market due to
presence of major API manufacturing countries like India and China. India alone
accounts for around 35% of the global market share owing to well-established
pharmaceutical production base. This is owing to factors such as increasing
pharmaceutical production, rising prevalence of motion sickness, and growing
healthcare spending in the region.
Key players related content comprises
Key players operating in the scopolamine API market are Daikin Industries
Limited, Viessmann Group, NIBE Group, Danfoss Group Global, Stiebel Eltron
Group, Mitsubishi Electric Corporation, United Technologies Corporation,
Panasonic Corporation, Glen Dimplex Group, The Bosch Group. These players
majorly focus on new product launches, expansions, and collaborations to
strengthen their market position.
Explorer more information on this
topic, Please visit @ https://www.pressreleasebulletin.com/scopolamine-api-market-growth-market-size-share-analysis/
Comments
Post a Comment